Created at	Source	Raw Value	Validated value
April 16, 2024, noon	usa	Cases of the first occurrence of symptomatic COVID-19 of any severity starting 7 days (≥8 days) after the study vaccination	Cases of the first occurrence of symptomatic COVID-19 of any severity starting 7 days (≥8 days) after the study vaccination
Dec. 24, 2022, 4 p.m.	usa	Cases of the first occurrence of symptomatic COVID-19 of any severity starting 14 days (≥15 days) after the study vaccination	Cases of the first occurrence of symptomatic COVID-19 of any severity starting 14 days (≥15 days) after the study vaccination
April 5, 2022, 8:30 p.m.	usa	Stage 1: Cases of symptomatic COVID-19 of any severity in Cohort 1 (conditional: only if cases in Cohort 1 reach a pre-set threshold, in consideration of the high vaccination rate and challenges in recruiting participants).;Stage 1: Cases of symptomatic COVID-19 of any severity in Cohort 2.;Stage 2: Cases of symptomatic COVID-19 of any severity in Cohort 1 (conditional: only if cases in Cohort 1 reach a pre-set threshold).;Stage 2: Cases of symptomatic COVID-19 of any severity in Cohort 2.	Stage 1: Cases of symptomatic COVID-19 of any severity in Cohort 1 (conditional: only if cases in Cohort 1 reach a pre-set threshold, in consideration of the high vaccination rate and challenges in recruiting participants).;Stage 1: Cases of symptomatic COVID-19 of any severity in Cohort 2.;Stage 2: Cases of symptomatic COVID-19 of any severity in Cohort 1 (conditional: only if cases in Cohort 1 reach a pre-set threshold).;Stage 2: Cases of symptomatic COVID-19 of any severity in Cohort 2.